Last reviewed · How we verify
NCT03343938
Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow Cabinet
NA trial testing Embryo handling in a closed station in ART in 78 participants. Completed in 30 November 2019.
31 October 2019
Quick facts
| Lead sponsor | Vida Recoletas Sevilla |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 78 |
| Start date | 31 October 2017 |
| Primary completion | 31 October 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Embryo handling in a closed station
Conditions studied
- ART — all drugs for ART →
Sponsor
Vida Recoletas Sevilla
Who can join
Adults 18 to 49, any sex, with ART. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is not yet a standardized system of human embryonic culture in vitro. In addition, technical improvements continually appear. The investigators recently carried out a study in which it shows that the grouped embryo culture at low oxygen tension (5% O2) in a benchtop incubator shows better success rates than individual culture at atmospheric oxygen tension (20% O2) in a conventional incubator. For these reasons, the investigators have decided to continue this research line to evaluate the efficacy of a new ART station with a closed environment in comparison of an open flow cabinet. This new system keeps a controled environment maintaining a carbon dioxide (CO2) concentration of 6% and a temperature of 37 degrees. A prospective randomized study will be carried out in which the manipulation of the gametes and pre-embryos of the patients will be carried out in open laminar flow cabinets or in a closed station that maintain the CO2 and temperature conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03343938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ART
Currently open trials in the same condition.
- NCT07278960 — Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies · recruiting
- NCT06484335 — RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV · Phase 1 · recruiting
- NCT07263490 — PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · recruiting
- NCT06334003 — Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology · recruiting
- NCT06374758 — Accelerated ART Initiation for PWHIV Who Are Out of Care · Phase 4 · recruiting
Other Vida Recoletas Sevilla trials
Trials by the same sponsor.
- NCT07088952 — Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle · NA · recruiting
- NCT06788379 — CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes · recruiting
- NCT04962100 — Capacitation-associated Protein Tyrosine Phosphorylation As a Possible Biomarker of Sperm Selection · NA · completed
- NCT03877939 — Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy · completed
- NCT04061486 — Sperm Separation Efficiency to Maximize Pregnancy Rates: MACS vs. FERTILE Chip · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03343938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vida Recoletas Sevilla
- Last refreshed: 12 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03343938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing